What Went Wrong in Monsanto-Syngenta Deal?

Your next video will start in

Recommended Videos

  • Info

  • Comments


June 24 (Bloomberg) –- Bloomberg’s Aaron Kirchfeld discusses what happened between Monsanto and Syngenta that sidelined the deal and how taxes are pushing U.S. firms into overseas M&A. He speaks to Anna Edwards and Mark Barton on Bloomberg Television’s “Countdown.” (Source: Bloomberg)

A look that moves are occurs.

Aaron, good to see you.

Why does it want zpwin -- syngenta about text?

No one admit it is just because of tax there.

Is strategic rationale for the two companies to combine.

You are talking about taking the largest seed company in monsanto to and the largest company in syngenta.

Tax inversions aren't that straight forward.

The u.s. politicians are looking at closing that loophole, and there would be a lot of anti-trust issues.

Is it going to come back, when do talks take place, and when could it come back?

Talks took place a few weeks ago.

They were very inform alin the lps, et cetera.

They were talking with vizcainoors as well.

Those collapsed about three, four or five weeks ago.

Whether it will come back is the million dollar convection.

A lot of bankers and journalists are hoping it would come back.

Our sources say we shouldn't rule it out because we have seen a lot of big deals in the past that were discussed, fell apart and did return.

We have discussed about companies taking money ban to the u.s. or trying to put their tax residency in europe so they pay lower tax.

The u.s. government isn't blind to this.

They are trying to close this hoop hole.

I think pfizer-astra stole the cake.

That got a lot of attention.

They talked about how they were going to close the loophole, but talking about it and doing it are two different things.

It would take up to 18 months

This text has been automatically generated. It may not be 100% accurate.


BTV Channel Finder


ZIP is required for U.S. locations

Bloomberg Television in   change